A double-blind, double-dummy, parallel-group, placebo-controlled, randomized study to assess the duration of the suppressive effects of desloratadine on the cutaneous allergen-induced wheal and flare (1) response after discontinuation.

Trial Profile

A double-blind, double-dummy, parallel-group, placebo-controlled, randomized study to assess the duration of the suppressive effects of desloratadine on the cutaneous allergen-induced wheal and flare (1) response after discontinuation.

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Jul 2014

At a glance

  • Drugs Desloratadine (Primary) ; Levocetirizine
  • Indications Allergic rhinitis; Hypersensitivity
  • Focus Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 29 Oct 2010 Last checked against ClinicalTrials.gov record.
    • 10 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top